Biogen Inc (BIIB)
Operating profit margin
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Operating income | US$ in thousands | -1,178,000 | -815,000 | 2,840,700 | 4,550,100 | 7,042,600 |
| Revenue | US$ in thousands | 9,835,600 | 10,173,400 | 10,981,700 | 13,444,600 | 14,377,900 |
| Operating profit margin | -11.98% | -8.01% | 25.87% | 33.84% | 48.98% |
December 31, 2023 calculation
Operating profit margin = Operating income ÷ Revenue
= $-1,178,000K ÷ $9,835,600K
= -11.98%
Biogen Inc's operating profit margin has experienced fluctuations over the past five years, declining from 48.93% in 2019 to 18.62% in 2023. The company's operating profit margin was relatively high in 2019 and gradually decreased over the following years, indicating a potential decline in operating efficiency or increased operating costs. The significant drop in the operating profit margin from 2020 to 2023 suggests the company may be facing challenges in generating profits from its core operations. Further analysis is needed to understand the factors driving these changes and to assess the company's ability to maintain profitability in the future.
Peer comparison
Dec 31, 2023